$0.208
-0.154 (-74.06%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
該買進 CASI Pharmaceuticals Inc 股票嗎？
CASI Pharmaceuticals Inc is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is facing significant challenges, including delisting from Nasdaq, a massive price drop, poor financial performance, and no positive trading signals. The lack of positive catalysts and the transition to OTC markets further increase the risk, making it unsuitable for the given investor profile.
CASI 股價於 Wednesday 收在 $0.21，此前下跌 -74.06%
CASI Pharmaceuticals Inc (CASI) last closed at $0.2075, losing -74.06%. These facts feed the 1-day and 1-week CASI price prediction above.
分析師一致預期
CASI Pharmaceuticals Inc（CASI）：買進 2、持有 0、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
CASI Pharmaceuticals Inc（CASI）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
CASI 季節性分析
Historically the probability of a positive September return for CASI is 4.88%. January offers the highest probability of a positive month at 36.07%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。